Journal profile · Andrology
Systems Biology in Reproductive Medicine
ISSN 1939-6368 · eISSN 1939-6376 · Taylor and Francis Ltd. · UNITED STATES · Bimonthly · Founded 2008
Systems Biology in Reproductive Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.04; subscription journal; APC charged, amount not published; median 187 days to acceptance (58 articles, last 24 months); community-reported acceptance: fairly easy; 39 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Systems Biology in Reproductive Medicine is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sperm and Testicular Function, Reproductive Biology and Fertility and Ovarian function and disorders, together about 52.4% of its articles. Its main subfields are Reproductive Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Systems Biology in Reproductive Medicine, SBiRM, is an international, peer-reviewed journal publishing high-quality, original basic, translational, and clinical research that is dedicated to bringing basic advances to the clinic. The journal highlights the use of systems approaches including genomic, cellular, proteomic, metabolomic, bioinformatic, molecular, and biochemical, to address fundamental questions in human and animal reproduction involving gametes, stem cells, developmental biology, toxicology, and clinical care in reproductive medicine spanning reproductive biology, reproductive medicine, and translational research. Specific areas of interest to the journal include: male factor infertility and germ cell biology, reproductive technologies (gamete micro-manipulation and cryopreservation, in vitro fertilization/embryo transfer (IVF/ET), and contraception. Research that is directed toward developing new or enhanced technologies for clinical medicine or scientific research in reproduction is of significant interest to the journal. Molecular Diagnostics is dedicated to bringing basic advances to the clinic. In this section, we will consider concept papers, reviews, assays that are in the early stages of development including their glitches, proof of principle, and implementation in the clinic. Manuscripts specifically addressing clinical observations and findings are encouraged and should be identified as Clinical as indicated in the article types listed below. Review Review and Hypothesis Research Communication Clinical: Research Communication Research Article Clinical: Research Article Molecular Diagnostics Clinical: Case Report Application Note Clinical: Application Note
From the journal's Aims & Scope
Research area (LetPub): Andrology
Editor-in-chief S.A. KrawetzPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sperm and Testicular FunctionMedicine22.1%
- Reproductive Biology and FertilityMedicine21.6%
- Ovarian function and disordersMedicine8.6%
- Reproductive Health and TechnologiesMedicine5.1%
- Reproductive System and PregnancyImmunology and Microbiology4.9%
- Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesBiochemistry, Genetics and Molecular Biology4.7%
- Assisted Reproductive Technology and Twin PregnancyMedicine3.2%
- Prenatal Screening and DiagnosticsMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Andrology | Zone 4 |
| Minor | Reproductive Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Andrology | Zone 4 |
| Minor | Reproductive Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Andrology | Zone 4 |
| Minor | Reproductive Biology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: OCLC, Adis International Ltd., CABI, EBSCOhost, E-psyche, Personal Alert (E-mail)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.04LetPub ·
- Impact factor (publisher) 2025
- 2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.8Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher) 2025
- 4.7Publisher website ·
- SJR 2026-06
- 0.7LetPub ·
- SJR (publisher) 2025
- 0.7Publisher website ·
- SNIP 2026-06
- 0.75LetPub ·
- SNIP (publisher) 2025
- 0.75Publisher website ·
- h-index
- 39LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 478OpenAlex ·
- 2-year mean citedness
- 3.18OpenAlex ·
- Self-citation rate
- 5%LetPub ·
- Share of gold OA articles
- 2.11%LetPub ·
Volume
- Articles per year
- 38LetPub ·
- Downloads per year (publisher)
- 251,000Publisher website ·
- Downloads per year (publisher) 2025
- 251,000Publisher website ·
Articles by year OpenAlex count · 829 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 5 | 17 |
| 2025 | 39 | 10 | 111 |
| 2024 | 28 | 21 | 149 |
| 2023 | 33 | 22 | 174 |
| 2022 | 32 | 9 | 488 |
| 2021 | 51 | 22 | 809 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
187 daysMedian, submission to acceptance · P25–P75 139 days – 240 days
- Acceptance to online
- median 28 days (58 articles)
- Submission to online
- median 212 days
- Sample
- 58 articles with submission and acceptance dates (61 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 14%Publisher website ·
- Acceptance rate (publisher) 2025
- 14%Publisher website ·
- Submission to first decision
- 10 daysPublisher website ·
- Submission to first decision 2025
- 10 daysPublisher website ·
- First decision after review
- 67 daysPublisher website ·
- First decision after review 2025
- 67 daysPublisher website ·
- Acceptance to publication
- 30 daysPublisher website ·
- Acceptance to publication 2025
- 30 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10
- application noteApplication NoteLength not stated
- clinical: application noteClinical: Application NoteLength not stated
- clinical: case reportClinical: Case ReportLength not stated
- clinical: research articleClinical: Research ArticleLength not stated
- clinical: research communicationClinical: Research CommunicationLength not stated
- molecular diagnosticsMolecular DiagnosticsLength not stated
- research articleResearch ArticleLength not stated
- research communicationResearch CommunicationLength not stated
- reviewReviewLength not stated
- review and hypothesisReview and HypothesisLength not stated
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Open access publishing is optional (hybrid). Authors may pay an APC for open access, or publish without charge under subscription model. Reduced or waived APC possible via institutional or funder agreements. Model summary
Systems Biology in Reproductive Medicine is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the di…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2008
- ISSN
- 1939-6368
- Electronic ISSN
- 1939-6376
- Latest issue on the website
- Volume 72, Issue 1 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Systems Biology in Reproductive Medicine
What CAS zone is Systems Biology in Reproductive Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Systems Biology in Reproductive Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Andrology / Reproductive Biology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Systems Biology in Reproductive Medicine?
The latest impact factor listed by LetPub is 2.04; CiteScore 4.7, h-index 62.
How long does peer review take at Systems Biology in Reproductive Medicine?
Based on the dates recorded on 58 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 187 days (interquartile range 139–240 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 14% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Systems Biology in Reproductive Medicine?
According to LetPub and DOAJ records, Systems Biology in Reproductive Medicine is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Systems Biology in Reproductive Medicine open access, and what is the APC?
Systems Biology in Reproductive Medicine is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .